Natera Inc

NASDAQ: NTRA
$97.15
-$0.06 (-0.1%)
Closing price May 7, 2024

NTRA Chart and Intraday Price

NTRA Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry SERVICES-MEDICAL LABORATORIES
Address 201 INDUSTRIAL ROAD, SUITE 410, SAN CARLOS, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 10,691.74M USD
Shares Outstanding 119,581,000
Natera Inc is a pioneering diagnostics company that offers a wide range of molecular testing services globally. Its innovative portfolio includes Panorama, a non-invasive prenatal test for chromosomal abnormalities, and Horizon, a carrier screening test. Natera also provides Vistara, Spectrum, Anora, Empower, and a non-invasive prenatal paternity product. Additionally, it offers Signatera for cancer recurrence monitoring, Altera for genomic profiling, Prospera for transplant rejection assessment, and Renasight for kidney gene panel testing. Natera enhances its offerings through partnerships and a cloud-based software, Constellation, facilitating access to its advanced algorithms and bioinformatics. Founded in 2003, Natera is headquartered in Austin, Texas.

NTRA Articles

The last trading day of 2023 got off to a flat start, and the two premier ride-sharing stocks both received downgrades on Friday morning.